Simplex Trading, LLC Axsome Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$3.35 Billion
Q1 2024

A detailed history of Simplex Trading, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 15,386 shares of AXSM stock, worth $1.23 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

15,386

Previous 20,813 26.08%

Holding current value

$1.23 Million

Previous $1.66 Million 25.91%

% of portfolio

0.04%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$69.39 - $97.64 $376,579 - $529,892	-5,427 Reduced 26.08%	15,386 $1.23 Million
Q4 2023 Feb 02, 2024	BUY	$57.42 - $83.61 $761,791 - $1.11 Million	13,267 Added 175.82%	20,813 $1.66 Million
Q3 2023 Nov 01, 2023	SELL	$69.25 - $82.21 $470,553 - $558,616	-6,795 Reduced 47.38%	7,546 $527,000
Q2 2023 Aug 04, 2023	BUY	$58.41 - $90.35 $804,948 - $1.25 Million	13,781 Added 2460.89%	14,341 $1.03 Million
Q1 2023 Apr 27, 2023	SELL	$58.39 - $75.0 $922,678 - $1.19 Million	-15,802 Reduced 96.58%	560 $34,000

Q4 2022 Feb 02, 2023	SELL	$39.94 - $79.72 $866,258 - $1.73 Million	-21,689 Reduced 57.0%	16,362 $1.26 Million
Q3 2022 Nov 04, 2022	BUY	$36.06 - $69.85 $422,298 - $818,013	11,711 Added 44.46%	38,051 $1.7 Million
Q2 2022 Aug 03, 2022	BUY	$21.74 - $46.75 $550,891 - $1.18 Million	25,340 Added 2534.0%	26,340 $1.01 Million
Q1 2022 May 02, 2022	SELL	$23.7 - $41.39 $472,269 - $824,778	-19,927 Reduced 95.22%	1,000 $41,000
Q4 2021 Feb 23, 2022	BUY	$30.7 - $43.36 $325,174 - $459,269	10,592 Added 102.49%	20,927 $790,000
Q3 2021 Oct 28, 2021	SELL	$19.91 - $68.26 $3,982 - $13,652	-200 Reduced 1.9%	10,335 $705,000
Q2 2021 Aug 12, 2021	BUY	$50.63 - $73.5 $516,324 - $749,553	10,198 Added 3026.11%	10,535 $710,000
Q1 2021 Apr 26, 2021	SELL	$55.91 - $81.44 $351,394 - $511,850	-6,285 Reduced 94.91%	337 $19,000
Q4 2020 Feb 02, 2021	SELL	$66.31 - $86.52 $281,485 - $367,277	-4,245 Reduced 39.06%	6,622 $0
Q3 2020 Oct 14, 2020	SELL	$68.34 - $85.84 $137,500 - $172,710	-2,012 Reduced 15.62%	10,867 $0
Q2 2020 Jul 13, 2020	SELL	$49.87 - $98.69 $545,727 - $1.08 Million	-10,943 Reduced 45.94%	12,879 $1.06 Million
Q1 2020 Apr 29, 2020	BUY	$41.2 - $101.31 $869,690 - $2.14 Million	21,109 Added 778.07%	23,822 $1.4 Million
Q4 2019 Feb 05, 2020	SELL	$16.71 - $106.24 $407,239 - $2.59 Million	-24,371 Reduced 89.98%	2,713 $280,000
Q3 2019 Oct 15, 2019	BUY	$20.24 - $29.16 $548,180 - $789,769	27,084 New	27,084 $548,000
Q2 2019 Jul 26, 2019	SELL	$13.46 - $25.75 $176,285 - $337,247	-13,097 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$2.63 - $16.34 $33,393 - $207,468	12,697 Added 3174.25%	13,097 $0
Q4 2018 Jan 16, 2019	BUY	$2.0 - $4.15 $600 - $1,245	300 Added 300.0%	400 $1,000
Q3 2018 Oct 23, 2018	BUY	$2.3 - $3.55 $229 - $355	100 New	100 $0

Others Institutions Holding AXSM

# of Institutions

290

Shares Held

37.1M

Call Options Held

401K

Put Options Held

464K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.44B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Axsome Therapeutics, Inc. Transaction History